Mesh.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Mesh.i » - entrée « Osteocalcin »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Osteoblasts < Osteocalcin < Osteoclasts  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 6.
Ident.Authors (with country if any)Title
000999 (2017) Yi-Ming Chen [Taïwan] ; Hsin-Hua Chen [Taïwan] ; Wen-Nan Huang [Taïwan] ; Tsai-Ling Liao [Taïwan] ; Jun-Peng Chen [Taïwan] ; Wen-Cheng Chao [Taïwan] ; Ching-Tsai Lin [Taïwan] ; Wei-Ting Hung [Taïwan] ; Chia-Wei Hsieh [Taïwan] ; Tsu-Yi Hsieh [Taïwan] ; Yi-Hsing Chen [Taïwan] ; Der-Yuan Chen [Taïwan]Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis.
001174 (2015) Fabrizio De Benedetti [Italie] ; Hermine Brunner ; Nicolino Ruperto ; Rayfel Schneider ; Ricardo Xavier ; Roger Allen ; Diane E. Brown ; Jeffrey Chaitow ; Manuela Pardeo ; Graciela Espada ; Valeria Gerloni ; Barry L. Myones ; James W. Frane ; Jianmei Wang ; Terri H. Lipman ; Kamal N. Bharucha ; Alberto Martini ; Daniel LovellCatch-up growth during tocilizumab therapy for systemic juvenile idiopathic arthritis: results from a phase III trial.
001375 (2014) Anne C. Bay-Jensen [Danemark] ; Adam Platt [Royaume-Uni] ; Inger Byrjalsen [Danemark] ; Philippe Vergnoud [France] ; Claus Christiansen [Danemark] ; Morten A. Karsdal [Danemark]Effect of tocilizumab combined with methotrexate on circulating biomarkers of synovium, cartilage, and bone in the LITHE study.
001765 (2012) Morten A. Karsdal [Danemark] ; Georg Schett ; Paul Emery ; Olivier Harari ; Inger Byrjalsen ; Andy Kenwright ; Anne C. Bay-Jensen ; Adam PlattIL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522).
001A07 (2010) Patrick Garnero [France] ; Elizabeth Thompson ; Thasia Woodworth ; Josef S. SmolenRapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone.
001D94 (????) Evangelos Terpos [Grèce] ; Kalliopi Fragiadaki ; Maria Konsta ; Cornelia Bratengeier ; Athanasios Papatheodorou ; Petros P. SfikakisEarly effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Osteocalcin" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Osteocalcin" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Osteocalcin
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021